Sr Scientist, Inflammation Biomarkers and Translational Research

Role: Lead biomarker strategy across multiple clinical development stages (PhI-III and registrational) for biopharma programs, focusing on inflammatory and fibrotic diseases. Responsibilities: define and execute biomarker assays (target engagement, pathway modulation, prognostic, predictive), oversee assay qualification and transfer, guide cross-functional teams, manage CRO/vendor relationships, support regulatory interactions, and contribute to scientific publications and presentations. Qualifications: PhD or MD/PhD in Immunology, Inflammation, or Translational Medicine; 5–8+ years industry experience with leadership in biomarker strategies; proven track record in scientific contributions, assay development, and clinical trial support. Preferred: expertise in liver/gut fibrosis, high-dimensional platforms, data analysis tools, prior regulatory engagement, and experience in regulated environments. HighValue: involvement in inflammatory/fibrotic disease research, translational studies with human samples, clinical biomarker development for PhI-III trials, and interaction with health authorities. WorkSetup: not specified, but involves external collaborations and cross-functional leadership.